🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 6 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/09/1999 | 65,59 | 67,27 | 65,59 | 66,67 | +1,64% | 2,57% | 6.247.442 |
| 21/09/1999 | 65,72 | 66,44 | 64,89 | 65,60 | -1,96% | 2,36% | 4.407.993 |
| 20/09/1999 | 65,66 | 67,09 | 65,48 | 66,91 | +2,09% | 2,45% | 2.962.382 |
| 17/09/1999 | 66,50 | 66,67 | 65,54 | 65,54 | -1,08% | 1,70% | 5.314.198 |
| 16/09/1999 | 65,06 | 66,26 | 65,00 | 66,26 | +2,02% | 1,92% | 3.169.781 |
| 15/09/1999 | 66,26 | 66,79 | 64,95 | 64,95 | -0,73% | 2,79% | 4.003.779 |
| 14/09/1999 | 65,96 | 66,20 | 65,12 | 65,42 | -1,53% | 1,63% | 3.592.230 |
| 13/09/1999 | 66,44 | 67,03 | 66,26 | 66,44 | -0,27% | 1,17% | 3.806.755 |
| 10/09/1999 | 66,20 | 66,85 | 65,60 | 66,62 | +0,90% | 1,89% | 3.289.672 |
| 09/09/1999 | 66,67 | 66,67 | 65,90 | 66,02 | +0,00% | 1,16% | 3.741.884 |
| 08/09/1999 | 65,36 | 66,14 | 64,77 | 66,02 | +0,54% | 2,10% | 7.157.526 |
| 07/09/1999 | 67,33 | 67,63 | 65,48 | 65,66 | -2,39% | 3,19% | 3.885.984 |
| 03/09/1999 | 66,56 | 67,33 | 65,84 | 67,27 | +3,30% | 2,24% | 4.699.861 |
| 02/09/1999 | 65,00 | 65,78 | 64,17 | 65,12 | -0,91% | 2,48% | 3.423.082 |
| 01/09/1999 | 64,11 | 65,96 | 63,99 | 65,72 | +2,51% | 3,07% | 3.761.167 |
| 31/08/1999 | 65,12 | 66,26 | 64,11 | 64,11 | -1,38% | 3,30% | 4.234.444 |
| 30/08/1999 | 65,30 | 66,26 | 64,95 | 65,00 | +0,00% | 2,01% | 2.777.934 |
| 27/08/1999 | 66,38 | 66,44 | 65,00 | 65,00 | -1,00% | 2,16% | 3.020.441 |
| 26/08/1999 | 66,91 | 66,97 | 65,54 | 65,66 | -2,39% | 2,14% | 3.175.545 |
| 25/08/1999 | 66,44 | 67,39 | 66,20 | 67,27 | +2,17% | 1,80% | 4.968.987 |
| 24/08/1999 | 66,62 | 66,73 | 65,36 | 65,84 | -1,52% | 2,06% | 4.379.382 |
| 23/08/1999 | 65,00 | 66,91 | 64,89 | 66,85 | +3,60% | 3,12% | 6.545.913 |
| 20/08/1999 | 62,56 | 64,83 | 62,50 | 64,53 | +3,24% | 3,72% | 5.964.902 |
| 19/08/1999 | 61,55 | 63,28 | 61,37 | 62,50 | +1,06% | 3,10% | 4.267.246 |
| 18/08/1999 | 62,44 | 62,74 | 61,84 | 61,84 | -0,29% | 1,43% | 3.809.061 |
| 17/08/1999 | 62,74 | 62,74 | 60,95 | 62,02 | +0,29% | 2,85% | 3.758.757 |
| 16/08/1999 | 61,07 | 61,84 | 60,71 | 61,84 | +1,67% | 1,86% | 4.337.253 |
| 13/08/1999 | 60,05 | 61,55 | 59,88 | 60,83 | +2,82% | 2,78% | 7.417.849 |
| 12/08/1999 | 58,21 | 60,47 | 58,21 | 59,16 | +1,74% | 3,89% | 10.038.897 |
| 11/08/1999 | 59,94 | 60,05 | 58,15 | 58,15 | -2,11% | 3,18% | 5.341.237 |